Published in Behav Sci Law on March 30, 2009
Clinical research with transcranial direct current stimulation (tDCS): challenges and future directions. Brain Stimul (2011) 3.25
Rethinking the thinking cap: ethics of neural enhancement using noninvasive brain stimulation. Neurology (2011) 1.27
Does the inferior frontal sulcus play a functional role in deception? A neuronavigated theta-burst transcranial magnetic stimulation study. Front Hum Neurosci (2012) 0.85
Modulation of untruthful responses with non-invasive brain stimulation. Front Psychiatry (2013) 0.84
Right inferior frontal gyrus activation as a neural marker of successful lying. Front Hum Neurosci (2013) 0.83
Prospects of functional magnetic resonance imaging as lie detector. Front Hum Neurosci (2013) 0.82
Transcranial direct current stimulation of the left dorsolateral prefrontal cortex shifts preference of moral judgments. PLoS One (2015) 0.77
The role of expectations, hype and ethics in neuroimaging and neuromodulation futures. Front Syst Neurosci (2014) 0.75
Disrupting dorsolateral prefrontal cortex by rTMS reduces the P300 based marker of deception. Brain Behav (2017) 0.75
The MacArthur Treatment Competence Study. III: Abilities of patients to consent to psychiatric and medical treatments. Law Hum Behav (1995) 3.57
Effects of pulse width and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. Brain Stimul (2008) 3.50
Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial. Arch Gen Psychiatry (2010) 3.14
The therapeutic misconception: problems and solutions. Med Care (2002) 3.05
Therapeutic misconception and the appreciation of risks in clinical trials. Soc Sci Med (2004) 2.97
Electric field depth-focality tradeoff in transcranial magnetic stimulation: simulation comparison of 50 coil designs. Brain Stimul (2012) 2.92
Lateral prefrontal cortex and self-control in intertemporal choice. Nat Neurosci (2010) 2.88
Parietal cortex and representation of the mental Self. Proc Natl Acad Sci U S A (2004) 2.73
Use of leverage to improve adherence to psychiatric treatment in the community. Psychiatr Serv (2005) 2.62
Capacity to provide informed consent for participation in schizophrenia and HIV research. Am J Psychiatry (2002) 2.41
The capacity to appoint a proxy and the possibility of concurrent proxy directives. Behav Sci Law (2006) 2.37
Models of consent to return of incidental findings in genomic research. Hastings Cent Rep (2014) 2.25
Mental health training for law enforcement professionals. J Am Acad Psychiatry Law (2005) 2.24
Proxy and surrogate consent in geriatric neuropsychiatric research: update and recommendations. Am J Psychiatry (2004) 2.20
Antidepressant-induced neurogenesis in the hippocampus of adult nonhuman primates. J Neurosci (2007) 2.12
Evaluating psychiatric disability: differences by forensic expertise. J Am Acad Psychiatry Law (2011) 2.04
A new brief instrument for assessing decisional capacity for clinical research. Arch Gen Psychiatry (2007) 1.96
The evolution of consent forms for research: a quarter century of changes. IRB (2010) 1.92
Elevated prefrontal cortex γ-aminobutyric acid and glutamate-glutamine levels in schizophrenia measured in vivo with proton magnetic resonance spectroscopy. Arch Gen Psychiatry (2012) 1.91
Transcranial magnetic stimulation in the treatment of major depressive disorder: a comprehensive summary of safety experience from acute exposure, extended exposure, and during reintroduction treatment. J Clin Psychiatry (2008) 1.89
Consent form readability and educational levels of potential participants in mental health research. Psychiatr Serv (2007) 1.89
Cooperation between fixed and low pH-inducible interfaces controls lipoprotein release by the LDL receptor. Mol Cell (2004) 1.89
The MacArthur Treatment Competence Study. I: Mental illness and competence to consent to treatment. Law Hum Behav (1995) 1.77
Unrealistic optimism in early-phase oncology trials. IRB (2011) 1.75
Attitudes and practices among internists concerning genetic testing. J Genet Couns (2012) 1.75
Assessment of capacity to consent to research among older persons with schizophrenia, Alzheimer disease, or diabetes mellitus: comparison of a 3-item questionnaire with a comprehensive standardized capacity instrument. Arch Gen Psychiatry (2005) 1.75
Maintaining informed consent validity during lengthy research protocols. IRB (2008) 1.62
Return of secondary genomic findings vs patient autonomy: implications for medical care. JAMA (2013) 1.60
Absence of histological lesions in primate models of ECT and magnetic seizure therapy. Am J Psychiatry (2004) 1.60
The MacArthur Treatment Competence Study. II: Measures of abilities related to competence to consent to treatment. Law Hum Behav (1995) 1.60
Two-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes. J Clin Psychiatry (2005) 1.57
Determining when impairment constitutes incapacity for informed consent in schizophrenia research. Br J Psychiatry (2007) 1.56
Neuropsychiatric applications of transcranial magnetic stimulation: a meta analysis. Int J Neuropsychopharmacol (2002) 1.51
Researchers' views on return of incidental genomic research results: qualitative and quantitative findings. Genet Med (2013) 1.48
The capacity to vote of persons with serious mental illness. Psychiatr Serv (2009) 1.48
Fundamentals of transcranial electric and magnetic stimulation dose: definition, selection, and reporting practices. Brain Stimul (2011) 1.45
The efficacy of acute electroconvulsive therapy in atypical depression. J Clin Psychiatry (2008) 1.44
Correlates of treatment-related decision-making capacity among middle-aged and older patients with schizophrenia. Arch Gen Psychiatry (2004) 1.43
Preservation of the capacity to appoint a proxy decision maker: implications for dementia research. Arch Gen Psychiatry (2011) 1.41
Questions on conflict of interest. Am J Psychiatry (2010) 1.38
Multimedia consent for research in people with schizophrenia and normal subjects: a randomized controlled trial. Schizophr Bull (2008) 1.37
Do clinicians follow a risk-sensitive model of capacity-determination? An experimental video survey. Psychosomatics (2006) 1.33
Twenty-five years of therapeutic misconception. Hastings Cent Rep (2008) 1.32
Can psychiatry cross the quality chasm? Improving the quality of health care for mental and substance use conditions. Am J Psychiatry (2007) 1.30
The Declaration of Helsinki and clinical trials: a focus on placebo-controlled trials in schizophrenia. Am J Psychiatry (2003) 1.29
Assessment of therapeutic misconception in older schizophrenia patients with a brief instrument. Am J Psychiatry (2006) 1.25
Enhancement of human cognitive performance using transcranial magnetic stimulation (TMS). Neuroimage (2013) 1.25
Repetitive transcranial magnetic stimulation (rTMS) in the treatment of obsessive-compulsive disorder (OCD) and Tourette's syndrome (TS). Int J Neuropsychopharmacol (2005) 1.22
Transcranial magnetic stimulation: a neuroscientific probe of cortical function in schizophrenia. Biol Psychiatry (2011) 1.22
Neocortical and hippocampal neuron and glial cell numbers in the rhesus monkey. Anat Rec (Hoboken) (2007) 1.21
Vagus nerve stimulation (VNS) for major depressive episodes: one year outcomes. Biol Psychiatry (2002) 1.17
Electroconvulsive therapy and repetitive transcranial magnetic stimulation in children and adolescents: a review and report of two cases of epilepsia partialis continua. Child Adolesc Psychiatr Clin N Am (2005) 1.17
Competence to consent to research among long-stay inpatients with chronic schizophrenia. Psychiatr Serv (2003) 1.16
Deliberative assessment of surrogate consent in dementia research. Alzheimers Dement (2010) 1.14
Magnetic seizure therapy improves mood in refractory major depression. Neuropsychopharmacology (2003) 1.13
A direct comparison of research decision-making capacity: schizophrenia/schizoaffective, medically ill, and non-ill subjects. Schizophr Res (2008) 1.12
Disclosure of information to potential subjects on research recruitment web sites. IRB (2008) 1.11
Issues for DSM-V: DSM-V should include a conceptual issues work group. Am J Psychiatry (2008) 1.10
A magnetic resonance spectroscopic imaging study of adult nonhuman primates exposed to early-life stressors. Biol Psychiatry (2003) 1.10
Direct injection of noise to the visual cortex decreases accuracy but increases decision confidence. J Neurophysiol (2011) 1.09
Efficacy and safety of deep transcranial magnetic stimulation for major depression: a prospective multicenter randomized controlled trial. World Psychiatry (2015) 1.09
Genetic testing in psychiatry: a review of attitudes and beliefs. Psychiatry (2011) 1.09
Ought we to require emotional capacity as part of decisional competence? Kennedy Inst Ethics J (1998) 1.08
Randomized controlled trial of the cognitive side-effects of magnetic seizure therapy (MST) and electroconvulsive shock (ECS). Int J Neuropsychopharmacol (2005) 1.08
Evidence for impaired cortical inhibition in patients with unipolar major depression. Biol Psychiatry (2005) 1.08
Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: assessment of relapse during a 6-month, multisite, open-label study. Brain Stimul (2010) 1.07
Research ethics. To protect human subjects, review what was done, not proposed. Science (2012) 1.06
Brief pulse and ultrabrief pulse right unilateral electroconvulsive therapy (ECT) for major depression: efficacy, effectiveness, and cognitive effects. J Clin Psychiatry (2014) 1.06
A transcranial magnetic stimulator inducing near-rectangular pulses with controllable pulse width (cTMS). IEEE Trans Biomed Eng (2008) 1.05
Randomized sham-controlled trial of repetitive transcranial magnetic stimulation in treatment-resistant obsessive-compulsive disorder. Int J Neuropsychopharmacol (2009) 1.05
Willingness of subjects with thought disorder to participate in research. Schizophr Bull (2005) 1.04
Information disclosure, subject understanding, and informed consent in psychiatric research. Law Hum Behav (1988) 1.03
Decisional capacity of severely depressed patients requiring electroconvulsive therapy. J ECT (2003) 1.03
Anesthetic considerations for magnetic seizure therapy: a novel therapy for severe depression. Anesth Analg (2006) 1.03
Drug-free research in schizophrenia: an overview of the controversy. IRB (1996) 1.03
Competence to complete psychiatric advance directives: effects of facilitated decision making. Law Hum Behav (2007) 1.02
The silent majority: who speaks at IRB meetings? IRB (2012) 1.02
Electric field strength and focality in electroconvulsive therapy and magnetic seizure therapy: a finite element simulation study. J Neural Eng (2011) 1.01
Transcranial magnetic stimulation in the acute treatment of major depressive disorder: clinical response in an open-label extension trial. J Clin Psychiatry (2008) 1.01
Regional electric field induced by electroconvulsive therapy in a realistic finite element head model: influence of white matter anisotropic conductivity. Neuroimage (2011) 1.01
The challenge of informed consent and return of results in translational genomics: empirical analysis and recommendations. J Law Med Ethics (2014) 1.01
Electroconvulsive therapy stimulus parameters: rethinking dosage. J ECT (2010) 1.01
Coil design considerations for deep-brain transcranial magnetic stimulation (dTMS). Conf Proc IEEE Eng Med Biol Soc (2008) 1.00
Modulation of motor cortex excitability in obsessive-compulsive disorder: an exploratory study on the relations of neurophysiology measures with clinical outcome. Psychiatry Res (2013) 1.00
Quick recovery of orientation after magnetic seizure therapy for major depressive disorder. Br J Psychiatry (2008) 1.00
The reporting of monetary compensation in research articles. J Empir Res Hum Res Ethics (2007) 0.98
Repetitive transcranial magnetic stimulator with controllable pulse parameters. J Neural Eng (2011) 0.97
Assessing competence to complete psychiatric advance directives with the competence assessment tool for psychiatric advance directives. Compr Psychiatry (2004) 0.97
Optimization of Golgi methods for impregnation of brain tissue from humans and monkeys. J Neurosci Methods (2003) 0.97
Prevalence and correlates of adequate performance on a measure of abilities related to decisional capacity: differences among three standards for the MacCAT-CR in patients with schizophrenia. Schizophr Res (2006) 0.97
Consent for intravenous thrombolysis in acute stroke: review and future directions. Arch Neurol (2007) 0.95
Variability of judgments of capacity: experience of capacity evaluators in a study of research consent capacity. Psychosomatics (2011) 0.95
Vagus nerve stimulation therapy randomized to different amounts of electrical charge for treatment-resistant depression: acute and chronic effects. Brain Stimul (2012) 0.95
Differential effects of high-dose magnetic seizure therapy and electroconvulsive shock on cognitive function. Biol Psychiatry (2008) 0.94
A primate model of anterograde and retrograde amnesia produced by convulsive treatment. J ECT (2004) 0.94
Focal electrically administered seizure therapy: a novel form of ECT illustrates the roles of current directionality, polarity, and electrode configuration in seizure induction. Neuropsychopharmacology (2009) 0.93
How closely do institutional review boards follow the common rule? Acad Med (2012) 0.93
Pulse width dependence of motor threshold and input-output curve characterized with controllable pulse parameter transcranial magnetic stimulation. Clin Neurophysiol (2013) 0.92
Decreasing procedural pain over time of left prefrontal rTMS for depression: initial results from the open-label phase of a multi-site trial (OPT-TMS). Brain Stimul (2009) 0.92
Treatment-related decision-making capacity in middle-aged and older patients with psychosis: a preliminary study using the MacCAT-T and HCAT. Am J Geriatr Psychiatry (2002) 0.91